Lupin Ltd Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Lupin Ltd Quarterly Results    (LUPL)

Here are the latest quarterly results of Lupin Ltd. For more details, see the Lupin Ltd financial fact sheet and Lupin Ltd share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Lupin Ltd Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-17
3
Dec-17
3
Mar-18
3
Jun-18
*
3
Sep-18
*
3
Dec-18
*
3
Mar-19
*
3
Jun-19
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m25,80025,31324,77638,55939,51145,04944,06344,184 
Other income Rs m7432405321,8422,307434865722 
Turnover Rs m26,54325,55225,30840,40141,81745,48344,92844,906 
Expenses Rs m20,38520,33120,23233,29034,01437,52335,34035,582 
Gross profit Rs m5,4154,9824,5455,2705,4964,1038,6778,605 
Depreciation Rs m9549921,0022,5902,6552,7982,8083,171 
Interest Rs m1066796687738798855856 
Profit before tax Rs m5,0984,1623,9793,8354,4109425,8795,300 
Tax Rs m1,2091,0701,0541,8111,7292,4782,9982,280 
Profit after tax Rs m3,8893,0922,9252,0232,681-1,5362,8813,021 
Gross profit margin %21.019.718.313.713.99.119.719.5 
Effective tax rate %23.725.726.547.239.2263.051.043.0 
Net profit margin %15.112.211.85.26.8-3.46.56.8 
Diluted EPS Rs 8.6 6.9 6.5 4.5 5.9 -3.4 6.4 6.7  
Diluted EPS (TTM) Rs 39.0 31.8 29.8 26.4 23.8 13.5 13.4 15.6  
 Subscriber Feature View View              
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Lupin Ltd 1QFY20 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   AMAR REMEDIES  AJANTA PHARMA  SUN PHARMA  CIPLA  ALEMBIC LTD  

Compare LUPIN With:   AMAR REMEDIES  AJANTA PHARMA  SUN PHARMA  CIPLA  ALEMBIC LTD  

Compare LUPIN With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Extend Losses; Yes Bank & Tata Steel Top Losers(12:30 pm)

Share markets in India have extended early losses and are presently trading deep in the red. Despite the cool-off in global oil prices, benchmark indices struggled as foreign investors.

Views on news

LUPIN Announces Quarterly Results (1QFY20); Net Profit Up 49.3% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, LUPIN has posted a net profit of Rs 3 bn (up 49.3% YoY). Sales on the other hand came in at Rs 44 bn (up 14.6% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

LUPIN Announces Quarterly Results (4QFY19); Net Profit Down 1.5% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, LUPIN has posted a net profit of Rs 3 bn (down 1.5% YoY). Sales on the other hand came in at Rs 44 bn (up 77.8% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN LTD 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of LUPIN LTD for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of LUPIN LTD. Also includes updates on the valuation of LUPIN LTD.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India (The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On (Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

A Rare Opportunity to Buy the Top 5 Stocks in the Market (The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

This Company Will Do Well Despite the Slowdown (The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted (Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN SHARE PRICE


Sep 19, 2019 02:11 PM

TRACK LUPIN

LUPIN - ALKEM LABORATORIES COMPARISON

COMPARE LUPIN WITH

MARKET STATS